Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Lancet Oncol. 2023 Apr 18;24(5):523–534. doi: 10.1016/S1470-2045(23)00146-8

Table 1.

Patient and treatment characteristics for photon and proton therapy cohorts.

Photon Cohort Proton Cohort P-value
Patients 101 94
Follow-up (years) 14.70(12.18–17.27 7.52 (6.28–8.53) ··
Age at RT (years) 8·98 (6.31–13.02) 9·.39 (6.39–13.38) 0·5224
Sex Female 46 (45.54% 49 (52.13%) 0·3914
Male 55 (54.46%) 45 (47.87%)
Race Asian 1 (0.99%) 2 (2.13%) <0·0001*
Black 22 (21.78%) 16 (17.02%)
Hispanic 2 (1.98%) ··
Other ·· 14 (14.90%)
White 76 (75.25%) 62 (65.95%)
CSF Shunt No 74 (73.27%) 88 (93.62%) 0·0002
Yes 27 (26.73%) 6 (6.38%)
Tumor Directed Procedures Total 197 140 0·0019
Surgery Multiple Procedures 46 31 0·1610
Single Procedures 50 59
No Procedures 5 4
Mean Dose (Gy) Brain 16·89 (14.46–18.79) 8·79 (6.74–10.61) <0·0001
Temporal Left 18·70 (13.87–21.52) 7·99 (5.60–10.62) <0·0001
Temporal Right 18·51 (14.17–22.49) 7·99 (5.60–10.76) <0·0001
*

When all patients are included, association of race by protocol is significant (P<0·0001. When the major categories Black and White are compared, association of race by protocol is not significant (P=0·8543).

RT=Radiation Therapy

96 photon therapy patients

90 proton therapy patients